Clinical Trials Browser

Phase 3 × Completed × selinexor × Clear all

NCT03555422 2026-04-13

ENGOT-EN5

Phase 3 Completed

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT03110562 2024-08-21

BOSTON

Phase 3 Completed

402 enrolled 22 charts 3 FDA

Multiple Myeloma, Recurrence

NCT04534725 2023-08-24

C-SMART

Phase 3 Completed

COVID-19, Neoplasms